Safety, side effects, and clinical oversight The FDA-labeled side-effect profile for GLP-1 receptor agonists and the GIP/GLP-1 dual agonist tirzepatide is well-characterized: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common
Diabetes (2013) 62:27526
Michele ShaneHead of School, The Children's House By providing technical support at the elementary, middle, and high school levels, Quarkmine helped grow this program into a leading STEM program in our area
To set expectations, approximately 30% of patients report experiencing pain at the injection site, and 20% of users experience redness or swelling after the injection
For a diet to help with weight loss, read Carnivore Diet Benefits